Purchase Order HHSN272201500330P
- Not listed
- This is a $80,000.00 firm fixed price purchase order awarded by the National Institute on Drug Abuse (NIDA), which is part of the Department of Health and Human Services (HHS). The contract has a total small business set aside and was awarded to the prime contractor Human Metabolome Technologies America, Inc., a Japan-based biotechnology company specializing in metabolomics. The contract engages Human Metabolome Technologies America to provide a range of testing, laboratory, and analytical...
- This firm fixed-price purchase order was awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the Department of Health and Human Services, to Human Metabolome Technologies America, Inc., a small disadvantaged business. The $16,000 contract is for basic scan metabolomics services, involving two sets of 40 samples. The contract has an ultimate completion date of June 30, 2023 and a ceiling value of $8,800. No set-aside designation was used for...
- This is a $75,000.00 firm fixed price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), which is part of the Department of Health and Human Services (HHS), to Human Metabolome Technologies America, Inc., a self-certified small disadvantaged business based in Allston, Massachusetts. The contract is for metabolomics profiling services, which includes conducting metabolomic assays, lipidomic analyses, and targeted metabolomics on samples related to various areas of...
- This $24,220 firm fixed-price purchase order contract was awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services, to Human Metabolome Technologies America, Inc., a small disadvantaged business based in Japan. The contract is for sample analysis services related to NICHD research, leveraging the vendor's metabolomics expertise and analytical platforms. No set-aside designation was used. The...
- This is a $80,000.00 firm fixed price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), which is part of the U.S. Department of Health and Human Services. The contract was awarded to Human Metabolome Technologies America, Inc., a small disadvantaged business based in Allston, Massachusetts. The contract is for metabolomics analysis services, including metabolomic assays, lipidomic analyses, targeted metabolomics, data acquisition, and testing methodologies. The...
- This is a $100,000.00 firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services, to Human Metabolome Technologies America, Inc., a small disadvantaged business based in Allston, Massachusetts. The contract is for targeted metabolomics analyses of human brain tissue samples, with a period of performance running until November 15, 2019. No set-aside designation was used for this award. Human Metabolome...
- This is a $9,800 firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Metabolon, Inc., a self-certified small disadvantaged business. The contract supports specialized metabolomics analysis services for various research programs, including those focused on veteran health, precision medicine, and environmental health impacts. Metabolon has been awarded multiple prime contracts and...
- This is a $14,820 firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the Department of Health and Human Services (HHS) National Institutes of Health (NIH), to Metabolon, Inc. The contract is for metabolomics analysis services to support research on the metabolic aspects of antiretroviral therapy (ART) initiation in patients with human immunodeficiency virus (HIV). Metabolon is a small disadvantaged business that...
- This federal contract award to Metabolon, Inc., a self-certified small disadvantaged business, was made by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). The $9,000 firm fixed-price purchase order does not have a set-aside designation. Metabolon is a leading provider of metabolomics solutions, offering advanced analytical methods and software for biomarker discovery in drug development and life sciences research. This award...
- This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Metabolon, Inc., a self-certified small disadvantaged business. The contract is for a project titled "Metabolic Profile of Cerebral Malaria; 100 Samples" with a ceiling value of $30,000.00 and a completion date of September 18, 2013. Metabolon, a leading provider of metabolomics solutions, has served as both a...
This is a firm fixed-price purchase order contract awarded by the National Institutes of Health's National Institute of Allergy and Infectious Diseases (NIAID) to Human Metabolome Technologies America, Inc. for $24,000.00. The contract is for metabolomics services, including metabolomic assays, lipidomic analyses, targeted metabolomics, data acquisition, and various testing methodologies. The contract has no set-aside designation and was awarded directly to the prime contractor, Human Metabolome Technologies America, Inc., a self-certified small disadvantaged business based in Japan that specializes in metabolomics technologies. The contract supports applications in drug design and development, covering areas such as cancer, neuroscience, oral health, and preclinical drug studies. This award is one of multiple federal contracts Human Metabolome Technologies America has received from agencies within the Department of Health and Human Services.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.0k | 1/27/15 |